Patrys' Contract Development Manufacturing Organisation (CDMO) advised the Company that specification testing using a revised process is still not complete, and that the revised process is proceeding through Quality Assurance and Quality Control approvals. In view of this, the CDMO has advised that specification testing for the drug substance produced in the recent manufacturing run...The post PAT-DX1 GMP specification testing update appeared first on Patrys.